Kaeda
Free · Sourced
← All cases
Accountable HQ
HIPAA compliance SaaS · Fort Worth, USA · bootstrapped
👤 Kevin Henry (Ran ops for a 309-bed hospital before founding Accountable in 2013 — he'd lived HIPAA from the inside.)🌐 siteLinkedIn

A hospital admin turned the compliance program only big hospitals could afford into a $199/mo self-serve tool.

Will it work? · our read
Boring but durable. A hospital insider quietly growing on a law that never goes away. No hype — a bootstrapped team owns the SMB HIPAA niche the giants find too small to chase.
01How the money moves
SMBs touch patient data — HIPAA is mandatory
Self-serves policies, training, risk assessments
Pays $199-799/mo to stay audit-ready
02The numbers
10,000+
companies served
site
125K+
staff trained
site
0
client HIPAA fines
site
Company and training counts are first-party site claims; revenue is a third-party Latka estimate, not disclosed. Latka
About $730K revenue in 2024 (Latka est.), up from $602K in 2023; bootstrapped, roughly 7-9 person team.
03Weight class — CENTStap an axis
ControlEntryNeedTimeScale
Control Mid
Owns its product, price and direct sales; but HHS sets the rules and giants can bundle HIPAA for free.
04The key move
A $100k guarantee
Most compliance vendors sell tools and disclaim all liability. In 2020 Accountable bundled up to $100k of breach and audit-cost protection into every plan — a de-risked buy rivals still won't match.
fact
The counter-intuitive move
Capped at $100k and hedged with conditions; a serious OCR penalty runs well into six or seven figures. It reassures buyers more than it truly insures them.
our read
05Where the moat is
What is actually hard to copy here:
Founder ran a 309-bed hospital's complianceLaw makes the demand mandatory, not optional$100k breach guarantee rivals won't copy13 years of SMB trust + zero client fines
06How it diesmedium confidence
It dies if the category commoditizes: policy templates are free, and funded SOC 2 giants (Vanta, Drata) bundle HIPAA for no extra cost — squeezing a thin-moat, self-serve SMB tool toward zero price. our read
Show evidence · counter
Evidence: Vanta and Drata now market HIPAA modules; HIPAA policy templates are freely downloadable; OCR rarely fines small practices, softening the urgency to keep paying.
Counter: But HIPAA recurs annually, and buyers want a HIPAA specialist they trust over a SOC 2 tool's side feature. 13 years and zero client fines is trust templates can't copy; Vanta and Drata still chase enterprise, leaving the low end open.
07Against rivals
Accountable$199-799/mo
Compliancy Groupsales-led, $$
Vanta$$$ enterprise
Drata$$$ enterprise
Vanta and Drata dwarf Accountable overall, but HIPAA is a side module for them; bars reflect focus on the cheap SMB HIPAA niche, where Accountable and Compliancy Group lead. our read
08Who uses it
Dental officesTherapy practicesHealth-tech startupsPharmaciesHome health agencies
Would it work for you?
Do you have insider access to a regulated niche the incumbents find too small — the way a hospital admin did with HIPAA?
Regulation forces demand, but the winner is usually the insider who lived the pain. We don't score you — you answer.
🚀Use it as a launchpada prompt for your own AI
Copy → paste into your AI → then develop it freely in the conversation.
You are a sharp, honest startup strategist. Use the proven case below as a launchpad for MY idea — help me find my own angle, not copy it. <my_profile> Domain I know: [your domain] My unfair advantage (access/audience): [your edge] Interests: [your interests] Resources & goal: [your resources] · [your goal] </my_profile> <case name="Accountable HQ" model="saas"> What it does: Accountable HQ sells SMBs a self-serve subscription that automates HIPAA policies, training, risk assessments, and vendor BAAs. Why it won (moat): A founder who ran hospital compliance, a market that is mandatory by law, 13 years of SMB trust with zero client fines, and a $100k breach guarantee rivals won't match. Weakest axis (CENTS): The category has a low barrier: policy templates are commoditized and funded SOC 2 platforms bundle HIPAA for free, eroding pricing power. How it could die: Accountable dies if HIPAA compliance commoditizes and funded SOC 2 giants bundle HIPAA for free, removing its pricing power and margin. </case> <task> Be a skeptical operator, not a cheerleader. No generic startup platitudes. If my angle is weak, say so plainly. First, a reality check: markets like this mostly fail. State the honest base rate (how crowded/hard is this?) and the ONE specific thing that would have to be true for ME to be the exception — grounded in my profile above. Then a compact table: - Fit — does this pattern suit my edge, or fight my gap? - Angle — my sharpest differentiation vs Accountable HQ (concrete, not "better UX") - Distribution — exactly where my first 100 users come from (this is the hardest part — be specific, not "content marketing") - Risk — its "how it dies" (above) in MY situation Finish with one line: "The single thing to do next." Use only the facts above; if data is thin, say so — never invent numbers. Then stay with me and go deeper on whatever I ask — tech stack, rough cost & time, the smallest MVP to test, pricing, or timing. </task>
✓ Copied — paste into your AI
👤Placeholders like [your domain] auto-fill from your profile — example values for now.Set up profile →
Sourcesupdated · daily
Real, verifiable company: founder Kevin Henry (ex-administrator of a 309-bed hospital), founded 2013 in Fort Worth; the 10,000+ companies, 125,000+ trained staff, and 'zero HIPAA fines' are first-party site/PR claims, unaudited. Revenue is NOT disclosed first-party — it is a third-party Latka estimate (about $730K, 2024, up from $602K in 2023). Latka also carries a second, conflicting entry of $5.4M / 40K customers that does not reconcile with $199-799/mo list pricing, so I use the conservative company-matched figure, mark it EST / not independently confirmed, and note the paying base is far smaller than 10,000+ companies (many use free training). No fabricated drama: this reads as a patient bootstrapped grind on a regulatory tailwind, not a dramatic pivot. We never score you.